P I Industries Ltd

Q3 FY26Fertilizers & Agrochemicals

P I Industries Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹2,497

Market cap₹42.6K Cr

P/E35.5

Updated23 Aug 2026

Read4 min read

The short version

Sequential volume growth expected beginning Q4 FY26, with recovery momentum building into FY27. Q4 FY26 expected to show sequential volume growth, with initial signs of recovery beginning.

From P I Industries Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Sequential volume growth expected beginning Q4 FY26, with recovery momentum building into FY27.
FY27 is anticipated to see overall revenue growth as industry conditions stabilize and new product ramp-up progresses.
Growth in the contract research and manufacturing (CRDMO) pharma business expected to strengthen as capabilities mature, targeting EBITDA positivity once topline hits INR 400-500 crore.
Domestic agrochemical growth projected to return on track from FY27 following subdued demand in FY26 due to high channel inventory and regulatory impacts.

2 more points management made on revenue & sales performance

Profitability & Margins

Q4 FY26 expected to show sequential volume growth, with initial signs of recovery beginning.
FY27 anticipated to see growth momentum building with gradual recovery after industry stabilization.
Earnings growth expected to be positive in FY27, supported by new product ramp-up and improving market conditions.
EBITDA margin may face short-term pressure due to investments, but strong gross margins (around 50-52%) are targeted sustainably.
New product portfolio continues to grow (~10% growth in new products for 9 months FY26), supporting de-risking strategy.
Biologicals contributing around 20% of revenue and expected to drive long-term growth with scalable global franchise.

2 more points management made on profitability & margins

See what P I Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

FY27 capex guidance is broadly INR 500 crore to INR 600 crore, with formal guidance expected post Board approval next quarter.
Plans are underway for setting up a pharma intermediate plant in India; further details to be announced soon.
Expansion from 2 to 3 multipurpose plants, with the third plant largely targeted for pharma business.
Company is actively evaluating various strategic and synergistic investment opportunities aligned with knowledge-led capabilities, both within AgChem and potentially outside it.

2 more points management made on capital expenditure plans

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech & Fertilizers Ltd₹180 Cr

Rev 2Mar 1

2Dharmaj Crop₹934 Cr

Rev 2Mar 2

3₹5.6K Cr

Rev 2Mar 3

4₹1.3K Cr

Rev 3Mar 1

5₹59.0K Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

No specific mention of any current or planned fundraising through debt or equity in the transcript.
The company highlights a debt-free balance sheet with net cash of INR 35 billion, indicating strong liquidity and financial flexibility.
Management emphasizes strategic investments funded through existing resources.
They are actively evaluating synergistic and knowledge-led growth opportunities but have not indicated any capital raising plans.

2 more points management made on fundraising & capital structure

See what P I Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

As of the quarter ending December 31, 2025, the order book stands at approximately $1.2 billion.
The company regularly shares updates on the order book and this figure was confirmed during the earnings call.
No indication of a decline in the order book was mentioned; relationships with large European and American customers continue to add new products and evaluations.

2 more points management made on order book & pipeline

P I Industries Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.6K Cr, net profit ₹200 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What P I Industries's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Indogulf Cropsci (Q3 FY26)
The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…
Rallis India Ltd (Q3 FY26)
Domestic B2C business growing steadily with 13% growth in Q3; volume expansion despite some price softness. Key concall takeaways from Rallis India's Q3 FY26…
Sharda Cropchem (Q3 FY26)
Capex planned in the range of INR 450-500 crores to support growth and registration activities. Key concall takeaways from Sharda Cropchem Ltd's Q3 FY26…
Krishana Phoschem Ltd (Q3 FY26)
It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand. Key concall takeaways from Krishana…

Compare:vs Coromandel International Ltd vs F A C T vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were P I Industries Ltd Q3 FY26 results?

Sequential volume growth expected beginning Q4 FY26, with recovery momentum building into FY27. Q4 FY26 expected to show sequential volume growth, with initial signs of recovery beginning.

What is P I Industries Ltd share price analysis?

P I Industries Ltd currently shows a neutral. The stock trades at a P/E of 35.5 with a market cap of ₹42,633 Cr. Investors should review the full earnings analysis for detailed insights.

Is P I Industries Ltd planning capital expenditure?

FY27 capex guidance is broadly INR 500 crore to INR 600 crore, with formal guidance expected post Board approval next quarter.

Keep P I Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.